X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

FBRX

Closed

Forte Biosciences Inc

12.44
-0.49 (-3.79%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 12.93
Day's Range: 11.7 - 13.48
Send
When Written:
 
1.01
Forte Biosciences Inc. is a clinical-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of inflammatory skin diseases and other related disorders. The company is headquartered in California, USA, and was founded in 2016. Forte Biosciences' lead product candidate, FB-401, is a live biotherapeutic that targets the underlying cause of atopic dermatitis, a chronic inflammatory skin disease. The company is also developing other products, including FB-201, a topical treatment for psoriasis, and FB-301, a treatment for acne. Forte Biosciences is focused on leveraging its proprietary microbiome platform to develop innovative therapies that can address unmet medical needs in dermatology and other therapeutic areas. The company is listed on the Nasdaq stock exchange under the ticker symbol "FBRX."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X